Dana Point, CA, United States of America

Alyssa M Larson

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Alyssa M. Larson: Pioneering Innovations in Liquid Protein Formulations

Introduction

Alyssa M. Larson, an innovative inventor based in Dana Point, CA, has made significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 11 patents, her work focuses on developing concentrated, low-viscosity, and low-volume liquid formulations that enhance the administration of proteins. These advancements have the potential to transform how medications are delivered to patients.

Latest Patents

Alyssa's latest patents include remarkable innovations. One patent features liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC). This formulation allows for rapid and convenient administration by subcutaneous or intramuscular injection, significantly improving patient experience compared to traditional intravenous methods. Her other notable patent involves liquid protein formulations that incorporate cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP). This innovation also enables the effective and swift injection of both low-molecular-weight and high-molecular-weight proteins, with improved viscosity through the addition of organophosphates.

Career Highlights

Alyssa is currently employed at Eagle Biologics, Inc., where her innovative spirit drives the advancement of high-quality pharmaceutical solutions. Her work embodies a commitment to enhancing the effectiveness and efficiency of drug delivery systems, thereby improving patient outcomes.

Collaborations

In her quest for innovation, Alyssa has collaborated with esteemed colleagues, including Alisha K. Weight and Alan Crane. Together, they contribute to a dynamic and forward-thinking environment at Eagle Biologics, Inc., fostering the exchange of ideas and research that amplify their collective impact in the field of biotechnology and pharmaceuticals.

Conclusion

Alyssa M. Larson stands out as a pivotal figure in the development of liquid protein formulations. Her groundbreaking patents not only elevate the standards of pharmaceutical compositions but also exemplify the transformative potential of innovation in healthcare. Through her work at Eagle Biologics, Inc., Alyssa continues to push the boundaries of drug delivery technologies, benefiting patients and the medical community at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…